GURUFOCUS.COM » STOCK LIST » USA » NAS » Lantheus Holdings Inc (NAS:LNTH) » Definitions » Profitability Rank
Switch to:

Lantheus Holdings Profitability Rank

: 6 (As of Jun. 2022)
View and export this data going back to 2015. Start your Free Trial

Lantheus Holdings has the Profitability Rank of 6.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Lantheus Holdings's Operating Margin % for the quarter that ended in Jun. 2022 was 28.25%. As of today, Lantheus Holdings's Piotroski F-Score is 7.


Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Lantheus Holdings Profitability Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Profitability Rank falls into.



Lantheus Holdings Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Lantheus Holdings has the Profitability Rank of 6.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Lantheus Holdings's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=63.204 / 223.723
=28.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Lantheus Holdings has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Lantheus Holdings Profitability Rank Related Terms

Thank you for viewing the detailed overview of Lantheus Holdings's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Lantheus Holdings Business Description

Lantheus Holdings logo
Traded in Other Exchanges
Address
331 Treble Cove Road, North Billerica, MA, USA, 01862
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.
Executives
Baylor-henry Minnie director C/O SCPHARMACUETICALS, INC. 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Yao Ying Vivian officer: Chief Human Resources Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Sabens Andrea officer: Chief Accounting Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Walker Carol officer: Senior Vice President, Quality C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Montagut Etienne officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Niedzwiecki Daniel officer: See Remarks C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Maeusli Heinz Christoph director SCHUETZENWEG 3 ENGELBURG V8 9032
Ber Gerard director C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Blanchfield Paul officer: Chief Commercial Officer C/O LANTHEUS HOLDINGS, INC. 331 NORTH BILLERICA MA 01862
Molnar Istvan officer: Chief Medical Officer C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Marshall Robert J. Jr. officer: CFO and Treasurer C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Bolla John J. director C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Pucel Kenneth director 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Thrall James H director 343 COMMERCIAL STREET #314 BOSTON MA 02109
Pruden Gary J director ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Lantheus Holdings Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)